Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Alcohol Use Disorder
NCT02711189Phase 1Withdrawn
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Mar 2016
- Primary completion
- Feb 2019
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in alcohol use disorder (AUD) (2 arms), sponsored by National Institute on Alcohol Abuse and Alcoholism. Primary endpoints: Alcohol Craving, Self-Administration, Stimulation Sedation; Cognitive Performance and 1 more. Planned start Mar 2016; status: withdrawn.
02
Drugs
oxytocin nasal spray
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02711189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02711189.